A quality by design approach in pharmaceutical development of non-viral vectors with a focus on mirna

HIGHLIGHTS

  • who: Ioana Toma et al. from the Department of Pharmaceutical Technology and Biopharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania have published the article: A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA, in the Journal: Pharmaceutics 2022, 1482 of /2022/
  • what: The aim of the QbD concept is to achieve product quality and robustness, to reduce product variability, and to increase pharmaceutical development and manufacturing efficiencies through sound and systematic analysis . The main focus of the researchers in developing a proper drug delivery . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?